ICO Investigates Data Security Concerns in Period and Fertility Trackers

The Information Commissioner’s Office (ICO) has launched a comprehensive review of period and fertility tracking apps, shedding light on growing concerns about data security and transparency.

These apps have gained popularity for helping users track menstrual cycles and providing valuable insights into various period-related health issues, including fertility calculations. However, the ICO’s investigation suggests that users are increasingly apprehensive about the safety of their shared data and the transparency of app developers.


User Worries


A recent poll commissioned by the ICO reveals that a significant portion of users harbour concerns regarding the privacy and security of their personal information.

Astonishingly, one-third of women have used these apps to monitor their periods or fertility. Within this group, 59% expressed concerns about data transparency, while 57% were worried about the security of the information they entrusted to these apps.

Further unsettling findings from the research indicate that over half of the app users observed an uptick in baby or fertility-related advertisements after signing up.

While some individuals responded positively to this marketing, a disconcerting 17% described the experience as distressing. The ICO’s Deputy Commissioner of Regulatory Policy, Emily Keaney, sympathised with these concerns, acknowledging the intensely personal and sensitive nature of the data involved.



The Need for Privacy and Transparency


Keaney emphasised that, like all health-related apps, organisations must prioritise user privacy and implement transparent policies. She stated, “This review is intended to establish both the good and bad of how the apps are working currently.”

The ICO’s comprehensive review aims to address a range of pressing questions. It will investigate whether app privacy policies are needlessly complex or confusing, leaving users unsure about the extent of data they’ve consented to share. Additionally, the inquiry will consider whether apps collect or retain excessive amounts of data and if users are exposed to distressing targeted advertisements without their consent.


Call for User Participation


The ICO is encouraging app users to come forward and share their experiences through a survey on its website. To ensure a well-rounded perspective, the ICO is also engaging in focus groups and user testing. Numerous women’s health groups have offered their support to this endeavour.

As part of its investigation, the ICO has contacted companies that offer period and fertility tracking apps, including some of the most popular ones available to UK users. This outreach seeks to uncover how these companies handle users’ personal information and whether they meet the necessary privacy and transparency standards.

In conclusion, the ICO’s review highlights the critical importance of user privacy and transparency in the rapidly growing world of health-related apps. As concerns mount, the regulatory body is determined to ensure that users can confidently manage their health data without compromising their personal information.